Please login to the form below

Not currently logged in
Email:
Password:

Zinbryta

This page shows the latest Zinbryta news and features for those working in and with pharma, biotech and healthcare.

Biogen and AbbVie pull MS drug Zinbryta from the market

Biogen and AbbVie pull MS drug Zinbryta from the market

Biogen and AbbVie have voluntarily withdrawn their multiple sclerosis drug Zinbryta from the market worldwide, saying the move is in the best interests of patients. ... The EMA recommends that doctors should review patients currently treated with

Latest news

More from news
Approximately 6 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics